Liu Shi Xin

Baru
40 tahun pengalaman
Lokasi: China, Xiamen
Klinik:Rumah Sakit Xiamen Humanity
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
Baca selengkapnya

Baru

Kunjungan dokter

Harga berdasarkan permintaan

Bookimed Insights: Spesialis Kanker kolon Teratas di China (2026)

Bookimed telah mengoordinasikan 53704 permintaan perawatan Kanker kolon di China, bekerja sama dengan 1 spesialis berperingkat tinggi. Dokter pada tabel ini dipilih berdasarkan kredensial internasional, keahlian klinis, dan hasil pasien. Peringkat 2026 disusun menggunakan data terverifikasi dari kasus pasien aktual dan program klinik mitra saat ini.

Peringkat	Dokter	pengalaman	Cocok Untuk	Apa yang Membedakan Mereka	Klinik & Lokasi	Konsultasi

FAQ

FAQ ini berasal dari pasien nyata yang mencari bantuan medis melalui Bookimed. Jawaban diberikan oleh koordinator medis berpengalaman dan perwakilan klinik terpercaya.

What are the average survival rates for colon cancer in China?

The 5-year relative survival rate for colon cancer in China is approximately 58% to 62%. Early-stage detection yields high survival rates between 85% and 96%. Outcomes correlate strongly with geographic location and the use of curative radical surgery over palliative care.

Stage I survival: Localized cancer survival reaches approximately 85% to 96%.
Regional disparities: Cities like Tianjin report survival rates as high as 82%.
Surgical outcomes: Patients undergoing radical surgery achieve a 73% survival rate.
Metastatic survival: Stage IV survival rates currently range from 30% to 34%.

Bookimed Expert Insight: Patient volume serves as a critical quality indicator in China. Fuda Cancer Hospital serves over 30,000 international patients. Xiamen Humanity Hospital manages around 1,000,000 patients annually. High-volume centers often provide faster access to specialized technologies like NanoKnife and CyberKnife M6 for complex cases.

Patient Consensus: Patients emphasize choosing tier-3 hospitals in major cities to ensure Western-level outcomes. Many recommend using specialized apps to track real-time follow-up statistics and manage post-operative care.

What are the most common treatment methods for colon cancer in China?

Colon cancer treatment in China focuses on surgical resection and minimally invasive techniques. Hospitals utilize laparoscopy for over 56% of cases to ensure faster recovery. Advanced centers combine specialized surgery with chemotherapy, targeted therapies, or immunotherapy based on genetic markers like KRAS and MSI status.

Surgical techniques: Complete Mesocolic Excision ensures radical removal of tumors and lymph nodes.
Advanced technologies: Jinshazhou Hospital offers CyberKnife M6 for precise, non-invasive robotic radiosurgery.
Innovative therapies: Fuda Cancer Hospital specializes in cryosurgery and NanoKnife for advanced-stage oncology.
Standard chemotherapy: Oncology centers frequently use FOLFOX or CapeOx regimens for postoperative care.

Bookimed Expert Insight: While most centers follow standard protocols, Fuda Cancer Hospital differentiates itself by applying over 10 types of minimally invasive therapies. Their focus on cryosurgery and vascular interventional therapy provides alternatives for patients who cannot tolerate aggressive chemotherapy after 30,000+ international cases.

Patient Consensus: Patients note that while surgery is the standard first-line approach, access to advanced diagnostics like PD-L1 testing often depends on whether you are in a major city center.

Is Stage 4 colon cancer treatable in China?

Stage 4 colon cancer is treatable in China through advanced multidisciplinary protocols in specialized oncology centers. Medical facilities utilize radical resection, NanoKnife ablation, and HIPEC to manage metastatic disease. Integration of modern drug therapies with traditional supportive care helps extend survival and maintain patient quality of life.

Available technologies: Centers use CyberKnife M6, Tomotherapy, and Da Vinci Robotic Systems for precision targeting.
Advanced procedures: Surgeons perform Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and NanoKnife ablation for complex cases.
International standards: Facilities like Fuda Cancer Hospital hold JCI accreditation and serve 30,000+ international patients.
Survival data: Specialized Chinese oncology centers report approximately 30-34% 5-year survival for Stage 4 cases.

Bookimed Expert Insight: Patients seeking treatment in China should prioritize JCI-accredited facilities in major hubs like Guangzhou. Data shows clinics like Fuda Cancer Hospital focus on minimally invasive therapies like cryosurgery and NanoKnife. These options serve as alternatives for those who may not tolerate standard high-dose chemotherapy well.

Patient Consensus: Patients note that getting imaging reviewed at a major Tier-1 city hospital is essential for accurate staging. Many emphasize that while costs for multimodal therapy are significant, the expertise in top academic centers is comparable to Western standards.

How is Traditional Chinese Medicine (TCM) used in colon cancer care?

Traditional Chinese Medicine (TCM) serves as a supportive integrative therapy for colon cancer in China. It combines herbal formulas, acupuncture, and lifestyle practices with surgery or chemotherapy to improve quality of life. These protocols focus on reducing treatment side effects and strengthening the immune response.

Side effect relief: Acupuncture and specific herbs alleviate chemotherapy-induced nausea, fatigue, and peripheral neuropathy.
Digestive support: Formulas like Si-Jun-Zi Decoction target bowel issues like diarrhea and abdominal pain.
Immune modulation: Ingredients like Astragalus and Ginseng are used to boost T-cell activity during recovery.
Physical recovery: Tai Chi and Qigong promote circulation and reduce anxiety after major bowel surgery.

Bookimed Expert Insight: Integrative care in China often combines ancient practices with advanced technology at the same facility. For example, Jinshazhou Hospital of Guangzhou University of Chinese Medicine offers CyberKnife M6 radiosurgery alongside traditional protocols. Our data shows these specialized centers provide comprehensive packages around $7,900 that include medical consultations and hospital stays.

Patient Consensus: Patients note that IV herbal drips and acupuncture are often provided directly in the hospital ward. They emphasize using these therapies to manage pain and speed up wound healing after a colon resection.

What advanced or `inoperable` tumour options are available in China?

China provides specialized treatments for inoperable tumors including cryosurgery, NanoKnife, and advanced immunotherapy. Facilities like Fuda Cancer Hospital are Joint Commission International (JCI) accredited. They specialize in treating late-stage cancer using over 10 types of minimally invasive therapies to manage complex cases.

Ablative techniques: Cryosurgery and NanoKnife destroy tumors while preserving nearby healthy tissue.
Interventional therapy: Vascular interventional therapy delivers high-dose medication directly to the tumor supply.
Radiation technology: CyberKnife M6 provides precise, non-invasive radiosurgery for inoperable or metastatic lesions.
Advanced procedures: Hyperthermic Intraperitoneal Chemotherapy (HIPEC) targets cancer cells specifically within the abdominal cavity.

Bookimed Expert Insight: While many countries focus on single-modality treatments for late-stage cases, specialized Chinese centers often combine cryosurgery with vascular intervention. Fuda Cancer Hospital has utilized this combined approach for over 30,000 patients from 100 countries. This high volume of international cases suggests a robust infrastructure for managing complex, multi-stage treatment protocols that may not be available elsewhere.

Patient Consensus: Patients with advanced tumors note that while treatments like CyberKnife can shrink inoperable lesions, the physical toll and fatigue are significant. Many emphasize the importance of verifying trial data before starting newer immunotherapies due to varying clinical outcomes.

Kanker kolon Dokter Terbaik di Xiamen - TOP-1 dokter

Dapatkan penawaran dari 3 spesialis teratas di China